Have a personal or library account? Click to login
Research Progress on Baduanjin Qigong for Depression Prevention and Treatment in the Last Decade Cover

Research Progress on Baduanjin Qigong for Depression Prevention and Treatment in the Last Decade

Open Access
|Nov 2025

Full Article

Introduction

Depression is a highly heterogeneous psychiatric disorder, characterized by core clinical features such as persistent low mood, loss of interest or pleasure, reduced energy, altered appetite and sleep, feelings of worthlessness or guilt, impaired concentration, indecisiveness, and recurrent thoughts of death or suicide (Ross, VanDerwerker, Saladin, & Gregory, 2023). These symptoms impose substantial psychological and somatic distress on patients and profoundly disrupt their daily activities, work performance, and social function (Ye & Dai, 2024). Consequently, as one of the most prevalent mental illnesses, depression has become an urgent global public health challenge that demands effective intervention and management strategies.

Historically, the management of depression has centered on pharmacotherapy and psychotherapy. As Viswanathan et al. (2020) report, pharmacological treatment remains the cornerstone, with selective serotonin reuptake inhibitors (SSRIs) and serotonin–noradrenaline reuptake inhibitors (SNRIs) serving as first-line options. These agents alleviate depressive symptoms by modulating central neurotransmitter activity. Although SSRIs and SNRIs are effective—particularly for major depressive disorder—their delayed onset and adverse effects frequently undermine adherence. Moreover, long-term use has been linked to an increased risk of suicidality in certain high-risk populations, especially adolescents (Wang, Guo & Zhang, 2016). For patients with treatment-resistant depression, rapidly acting agents such as ketamine have drawn considerable attention. While ketamine can induce rapid antidepressant effects, concerns about dependence and potential neurotoxicity with prolonged use currently limit its broad clinical application (Kim, Suzuki, Kavalali & Monteggia, 2024).

Psychotherapeutic interventions—most notably cognitive-behavioral therapy (CBT), which targets maladaptive cognitive patterns—have shown substantial efficacy in the treatment of chronic depression (Wang et al., 2016). Nonetheless, the benefit of psychotherapy alone is moderated by patient-specific factors such as treatment preference and personality traits, thereby limiting its effectiveness for some individuals (Hou, Liu & Zhang, 2018).

Despite the various treatment options available for the prevention and management of depression, limitations remain, including efficacy variations due to individual differences, side effects of medications, and treatment tolerance in certain patients (Pampallona et al., 2004). This highlights the need to explore new therapeutic strategies in clinical practice to improve efficacy and reduce adverse reactions. In recent years, in addition to pharmacotherapy and psychotherapy, exercise as a means to alleviate stress, anxiety, and depression has gradually gained attention (Brondino et al., 2017).

Baduanjin originated in China during the Song Dynasty (960 – 1279 CE) and consists of eight movements. It is a traditional form of Qigong characterized by its simplicity, ease of learning, and slow, gentle movements, with an emphasis on the coordination of breath and movement. The practice focuses on slow and controlled body stretches, combined with deep and prolonged breathing (Li et al., 2022). Each movement targets different meridians in the body (which, according to Traditional Chinese Medicine (TCM), are pathways connecting various organs and promoting overall health). Baduanjin has been shown to effectively enhance flexibility, balance, and inner tranquility. Unlike vigorous exercise, Baduanjin requires no equipment and can be practiced anywhere, making it particularly suitable for relieving stress and boosting energy.

Baduanjin has demonstrated broad application prospects in clinical practice and has been used in the prevention and treatment of chronic orthopedic diseases, such as cervical spondylosis and lumbar disc herniation (Zhu & Niu, 2021). In the field of internal medicine, Baduanjin has been shown to effectively lower blood glucose and glycated hemoglobin levels in patients with type 2 diabetes, thereby promoting overall health (You, Fang, & Guan, 2016). Furthermore, due to its characteristics of low-intensity, sustained aerobic exercise, Baduanjin has been applied in the treatment of chronic obstructive pulmonary disease, stroke patients, as well as chronic low back pain and exercise-induced fatigue (Cao, Zhang, Zeng, et al., 2021; Zhang & Yang, 2017).

It is noteworthy that Baduanjin promotes both physical and mental health development through enhancing physical fitness, adjusting breathing, and facilitating self-reflection. On the psychological level, the focus and relaxation during practice help reduce negative thinking, alleviate anxiety, and improve depressive symptoms (Wang & Yan, 2015). On the physiological level, the coordination of movement and breath not only improves autonomic nervous function but also increases cerebral blood flow, stimulates the secretion of neurotransmitters such as serotonin and endorphins, and reduces cortisol levels, thereby enhancing mood (Ye and Wang, 2024) (Figure 1). Several scholars have reported randomized trials on Baduanjin in the prevention and treatment of depression, providing positive data results (Wei Lai et al., 2024). Additionally, some studies have explored the combined use of Baduanjin with medications, fitness exercises, and Mindfulness-Based Stress Reduction (MBSR) therapies, demonstrating psychological regulation effects in individuals with varying degrees of depression (Yang et al., 2024).

Figure 1.

Mechanism of Baduanjin in the Prevention and Treatment of Depression on the Physical and Psychological Levels

However, despite the growing interest and research in both academia and clinical practice exploring the value of Baduanjin in the prevention and treatment of depression, there is still a lack of systematic reviews on its efficacy and safety in depression prevention. Therefore, this study reviews the relevant research on Baduanjin in the prevention and treatment of depression over the past decade, aiming to explore whether there is sufficient evidence to support its use as an effective, safe, and widely promotable approach for the prevention and management of depression.

Purpose

The purpose of this literature review is to evaluate the efficacy and safety of Baduanjin Qigong in the prevention and treatment of depression. This study is situated within the context of the global mental health crisis, where conventional pharmacological andpsychotherapeutic treatments are constrained by side effects, inconsistent patient responses, and poor tolerability. By reviewing peer-reviewed studies published between 2015 and 2024, this review will (a) examine the current applications of Baduanjin across different populations and conditions, (b) assess its effectiveness as either a stand-alone treatment or in combination with other therapies for depression, and (c) confirm the safety of Baduanjin as a treatment for depression. The aim of this study is to determine whether Baduanjin provides an effective, safe, and scalable therapeutic option for the treatment of depression.

Methodology
Literature Sources

The literature for this study was primarily drawn from PubMed and the China National Knowledge Infrastructure, which are widely recognized for their comprehensive coverage of international and Chinese research in the field of health and wellness, particularly related to traditional medicine.

Search Strategy

To ensure both breadth and precision, PubMed and the China National Knowledge Infrastructure were searched using Chinese and English terms for “Baduanjin,” “depression,” “efficacy,” “safety,” and “intervention,” combined with Boolean operators (AND, OR). The search period was restricted to 2015–2024 to capture the most recent evidence. Using the above strategies, literature related to the application of Baduanjin in the prevention and treatment of depression was screened, and the selected studies were further filtered (Figure 2).

Figure 2:

Flowchart of Literature Selection for the Prevention and Treatment of Depression with Baduanjin

Inclusion Criteria

The inclusion criteria for this study are as follows: the research involves the application of Baduanjin as an intervention in the prevention and treatment of depression; the study clearly evaluates the efficacy and/or safety of Baduanjin; the study design is a randomized controlled trial (RCT); the study was published in Chinese or English journals between 2015 and 2024.

Exclusion Criteria

The exclusion criteria are as follows: the study involves non-clinical samples or animal experiments; the study does not involve Baduanjin intervention or fails to assess its efficacy and safety; the study design is not an RCT; the study was not published between 2015 and 2024; the study is published in a language other than Chinese or English. In the end, 16 articles meeting the inclusion criteria were selected.

Data Standardization and Database Construction

To ensure standardized and efficient reference management, Zotero was used throughout the screening process to build a dedicated database. This database contained every article that satisfied the inclusion criteria, with detailed records of each study’s key information. It also stored the DOI, journal details, and PDF links, ensuring full traceability and completeness. All reference data were entered and updated in a uniform format to maintain consistency and integrity.

Data Analysis

This study employs a qualitative analysis approach to systematically evaluate the literature. First, all studies meeting the inclusion criteria were reviewed and organized, assessing the similarities and differences in methods and efficacy of Baduanjin interventions for depressive symptoms. Second, efficacy data from the literature were primarily summarized using descriptive statistics. All analysis results were based mainly on the data and conclusions provided in the original studies (Table 1)

Table 1:

Intervention Studies on the Prevention and Treatment of Depression with Baduanjin

No.Author InformationParticipant Population (n)Experimental Groups (n)
1Jing et al. (2018)Homebound older adults (n=120)A1: Cognitive Behavioral Therapy Group (n=40/40)A2: Baduanjin Group (n=40/39)A3: Combined Intervention Group (n=40/39)
2Li and Luo (2024)Patients with chronic cor pulmonale (n=86)A1: Routine Care Group (n=43/43)A2: Baduanjin Group (n=43/43)
3Li et al. (2022)Patients with postmenopausal osteoporosis (n=50)A1: Chinese Herbal Medicine Group (n=15/15)A2: Baduanjin Group (n=17/17)A3: Combined Intervention Group (n=18/18)
4Lv et al. (2022)Patients with depression (n=50)A1: Conventional Muscle Relaxation Group (n=25/23)A2: Baduanjin Group (n=25/21)
5Ma et al. (2023)Patients in the convalescent phase of COVID-19 (n=70)A1: Conventional Medical Care Group (n=35/35)A2: Usual Care plus Baduanjin Group (n=35/35)
6Suo and Yu (2016)Perimenopausal women (n=60)A1: Conventional Therapy Group (n=30/30)A2: Chinese Herbal Medicine plus Baduanjin Group (n=30/30)
7Tan and Tan (2020)University students with mild to moderate depression (n=70)A1: Usual Daily Activity Group (n=35/35)A2: Baduanjin Group (n=35/35)
8Wang et al. (2021)Patients with COVID-19 (n=60)A1: Conventional Medical Care Group (n=30/30)A2: Usual Care plus Baduanjin and Five-Element Music Therapy Group(n=30/30)
9Wang et al. (2023)Asymptomatic individuals with COVID-19 infection (n=200)A1: Conventional Medical Care Group (n=100/81)A2: Usual Care plus Integrated Baduanjin and Five-Element Music Therapy Group (n=100/96)
10We et al. (2024)University students (n=152)A1: Baduanjin Course Group (n=76/76)A2: Conventional Physical Education Course Group (n=76/76)
11Xiao et al. (2024)Patients with chronic heart failure and comorbid depression (n=120)A1: Western Medication Group (n=40/40)A2: Chinese Herbal Medicine Group (n=40/40)A3: Integrated Chinese Herbal Medicine and Baduanjin Group (n=40/40)
12Yan et al. (2024)Patients with moderate depression (n=40)A1: Western Medication Group (n=20/20)A2: Combined Baduanjin and Relaxation Qigong Group (n=20/20)
13Yang et al. (2021)Patients with depression and comorbid insomnia (n=58)A1: Western Medication Group (n=29/29)A2: Pharmacotherapy plus Baduanjin Group (n=29/29)
14Yang et al. (2024)Patients with schizophrenia in the recovery phase (n=100)A1: Baduanjin Group (n=50/50)A2: Integrated Baduanjin and MBSR Group (n=50/50)
15Ye & Wang (2024)Patients with major depressive disorder (n=50)A1: Conventional Medical Care Group (n=25/25)A2: Usual Care plus Adjunctive Baduanjin Group (n=25/25)
16Zhang et al. (2017)Patients with depression (n=124)A1: Western Medication Group (n=62/62)A2: Pharmacotherapy plus Adjunctive Baduanjin Group (n=62/62)
Ethical considerations

This research did not require IRB approval because it is a literature review, which involves the synthesis and analysis of existing published data and does not involve human subjects, animal experiments, or the collection of new primary data.

Results

The results of this study are presented in three layers. First, the current applications of Baduanjin across different diseases and populations are summarized to provide background for understanding its value in depression. Second, the effectiveness of Baduanjin under different intervention modalities for the prevention and treatment of depression is analyzed, highlighting its role within integrative therapeutic approaches. Finally, its safety is discussed to comprehensively evaluate its clinical feasibility.

Effectiveness of Different Intervention Modalities in the Prevention and Treatment of Depression

In existing research and clinical practice, Baduanjin has been employed both as an independent intervention and in combination with pharmacotherapy, psychological therapies, or other forms of physical exercise, thereby constituting multi-level comprehensive treatment strategies. A key issue that warrants further investigation is the specific efficacy of these different intervention protocols in the prevention and treatment of depression.

Standalone Intervention

In experimental studies on the prevention and treatment of depression, Baduanjin is often employed as a stand-alone intervention. Evidence from intervention trials across diverse populations has demonstrated that, even without the integration of other therapeutic modalities, Baduanjin can produce significant improvements in psychological well-being.

For instance, Li et al. (2022) conducted a 16-week Baduanjin intervention among postmenopausal women with osteoporosis and found a significant reduction in depressive symptoms, with the Self-Rating Depression Scale (SDS) scores decreasing from 50.03 ± 1.85 to 47.06 ± 1.81 (p < 0.05), indicating that depression was effectively alleviated through Baduanjin alone. Similarly, Lv et al. (2022) confirmed the efficacy of Baduanjin, reporting that after six weeks of intervention, participants with depression exhibited significantly lower Hamilton Depression Scale (HAMD) scores compared to the control group (p < 0.01)

Furthermore, Tan and Tan (2020) implemented a year-long Baduanjin intervention among university students and demonstrated that it effectively reduced mild to moderate depressive symptoms, with a significant decline in SDS scores (p < 0.01). Finally, research by Wei et al. (2024) revealed that even a low-frequency protocol, consisting of a 90-minute session once per week, led to a significant reduction in Patient Health Questionnaire-9 (PHQ-9) scores among university students, further supporting the positive impact of Baduanjin as an independent intervention.

Collectively, these findings indicate that Baduanjin, when applied as a stand-alone modality, can significantly alleviate depressive symptoms across diverse populations. This not only confirms its therapeutic efficacy but also highlights its preventive potential, extending beyond clinical groups to broader healthy populations (Table 2).

Table 2:

Effectiveness of Baduanjin as a Single Intervention

Authors (Year)Study PopulationIntervention ProtocolOutcomes
Li et al. (2022)Patients with postmenopausal osteoporosis5 sessions/week, 45 minutes/session, for 16 weeks (with initial professional guidance).After the 16-week intervention, the Baduanjin group's SDS score decreased significantly from a baseline of 50.03 ± 1.85 to 47.06 ± 1.81 at week 16, with a mean reduction of 2.96 points (p < 0.05).
Lv et al. (2022)Patients with depression1 session/day, 60 minutes/session, for 6 weeks.After six weeks of intervention, the depression level (HAMD) in the Baduanjin group was significantly lower than that in the control group, with a statistically significant difference (P < 0.01).
Tan and Tan (2020)University students with mild to moderate depression5 sessions/week, 40 minutes/session, for one academic year.After one academic year of intervention, the SDS score in the Baduanjin group decreased significantly from 60.06 ± 4.63 to 57.80 ± 4.27 (P < 0.01).
Wei et al. (2024)University students1 session/week, 90 minutes/session, for 18 weeks.The PHQ-9 score in the control group decreased significantly from 7.54 ± 3.03 to 5.41 ± 4.11 (P < 0.01).
Combination with Pharmacotherapy Interventions

Although Baduanjin, when used as a stand-alone intervention, can alleviate depressive symptoms, its therapeutic efficacy remains limited in patients with severe depression or those presenting with comorbid conditions. In such cases, combining Baduanjin with pharmacotherapy can significantly enhance overall treatment outcomes and provide a more comprehensive therapeutic approach. Within the context of Western medicine, Baduanjin often serves as an adjunct modality. For example, Zhang et al. (2017) demonstrated that the combination of paroxetine with Baduanjin exercise yielded superior outcomes compared to pharmacotherapy alone in patients with depression.

Moreover, integrating Baduanjin with medication not only reduces depressive symptoms but also improves overall health status. Yang et al. (2021) reported that, in the treatment of depression accompanied by insomnia, the combination of Baduanjin with agomelatine produced favorable results, with the combined group showing significantly greater improvements in sleep quality compared to the control group (P < 0.05). In addition, therapeutic strategies combining Baduanjin with TCM have also shown promising efficacy. Among perimenopausal or postmenopausal women with depression, the herbal formula Jieyu Fang combined with Baduanjin yielded significant clinical benefits, including positive effects on bone mineral density and lower-limb balance (Suo and Yu, 2016). Furthermore, in cases of chronic heart failure accompanied by depression, patients treated with Baduanjin in conjunction with Guipi Tang exhibited significantly lower HAMD scores compared to those receiving medication alone (P < 0.05), further confirming the effectiveness of integrating Baduanjin with TCM across different populations (Xiao et al, 2024).

In summary, whether combined with Western medication or traditional Chinese herbal therapy, Baduanjin demonstrates superior therapeutic outcomes for depression compared to either modality used in isolation (Table 3).

Table 3:

Effectiveness of Baduanjin Combined with Pharmacological Intervention

Authors (Year)Study PopulationIntervention ProtocolOutcomes
Suo and Yu (2016)Perimenopausal womenReceived Chinese herbal medicine, plus Baduanjin practice (60 minutes/session, once daily) for 3 months.In the experimental group, the HAMD score decreased significantly from 27.20 ± 3.04 to 11.38 ± 3.61 after the intervention (P < 0.01).
Xiao et al. (2024)Patients with chronic heart failure and comorbid depressionReceived Chinese herbal medicine, plus Baduanjin (3 sessions/week for 4 weeks in hospital, followed by 2 months of home practice).The experimental group showed a significant reduction in the HAMD score from 18.62 ± 3.02 to 10.23 ± 3.88 after the intervention (P < 0.05).
Yang et al. (2021)Patients with depression and comorbid insomniaReceived pharmacotherapy, plus Baduanjin (30 minutes/session, twice daily) for 8 weeks.A significant decrease in the HAMD score was observed in the experimental group, from 25.03 ± 5.05 to 11.55 ± 5.54 following the intervention (P < 0.01).
Zhang et al. (2017)Patients with depressionReceived pharmacotherapy, plus Baduanjin (30 minutes/session, twice daily) for 6 weeks.In the experimental group, the HAMD score decreased significantly from 35.8 ± 6.2 to 8.2 ± 2.2 after the intervention (P < 0.05).
Combination with Psychotherapeutic Interventions

Beyond its application as a stand-alone intervention or in combination with pharmacotherapy, the integration of Baduanjin with psychological interventions offers dual benefits by simultaneously promoting physical regulation and psychological support. This combined approach has been shown to significantly enhance treatment efficacy and improve overall mental health in patients with depression, with minimal adverse effects.

Jing et al. (2018), in their investigation of Baduanjin combined with cognitive-behavioral therapy (CBT) among home-dwelling older adults, found that the combined intervention group demonstrated superior outcomes in depressive symptoms, quality of life, and physical functioning compared to groups receiving CBT or Baduanjin alone. Given the high prevalence of negative emotions among patients with chronic illness, Li and Luo (2024) reported that, after a two-month intervention in patients with chronic cor pulmonale, the combination of Baduanjin and traditional Chinese emotional care not only effectively addressed cardiopulmonary conditions but also prevented the onset of anxiety and depression.Furthermore, Yang et al. (2024) revealed that, among patients in the recovery phase of schizophrenia, an intervention combining Baduanjin with MBSR significantly reduced SDS scores, indicating notable improvements in depressive symptoms.

Collectively, these findings underscore that Baduanjin combined with psychological interventions yields substantial benefits in alleviating depressive symptoms and enhancing overall health, warranting broader integration into clinical practice (Table 4).

Table 4:

Effectiveness of Baduanjin Combined with Psychological Intervention

Authors (Year)Study PopulationIntervention ProtocolOutcomes
Jing et al. (2018)Homebound older adultsA 6-month integrated Baduanjin and cognitive-behavioral therapy (CBT) protocol, including bi-weekly home visits (1–1.5 hours/session) during the first 3 months, followed by monthly sessions in the maintenance phase.The joint intervention group showed a Significant Reduction in the Depression score from 5.90 ± 2.43 to 3.46 ± 1.75 after the 6-month intervention (P < 0.05).
Li and Luo (2024)Patients with chronic cor pulmonaleA 2-month combined regimen of TCM emotional nursing and Baduanjin exercise, delivered once daily (30 minutes/session) in addition to standard care.The combined intervention significantly reduced the SDS score from 56.81 ± 4.78 to 41.74 ± 4.74, demonstrating a greater improvement in depressive symptoms compared to routine care alone (P < 0.05).
Yang et al. (2024)Patients with schizophrenia in the recovery phaseAn 8-week integrated intervention comprising daily 30-minute Baduanjin practice combined with 20-minute MBSR sessions administered five times per week.The combined intervention significantly reduced SDS depression scores from 60.53±4.41 to 47.55±3.39, demonstrating superior improvement compared to the single-intervention group (P<0.001).
Combination with Other Interventions

In addition to the aforementioned intervention modalities, Baduanjin has also been integrated with medical nursing, music therapy, and other forms of physical exercise in the treatment of depression. In studies involving patients with COVID-19, Ma et al. (2023) combined routine nursing care with Baduanjin and reported a significant reduction in PHQ-9 scores, with the intervention group showing markedly greater improvement than the control group (P < 0.01). Similarly, Wang et al. (2021) and Wang et al. (2023) implemented a combined intervention consisting of routine care, Baduanjin, and Five-Element Music Therapy, and observed significant decreases in both HAMD and PHQ-9 scores, with the observation groups outperforming the control groups.Furthermore, Yan et al. (2024) explored the effects of integrating Baduanjin with relaxation exercises in individuals with moderate depression. Their findings indicated a significant reduction in HAMD scores among patients receiving the combined intervention of routine care, Baduanjin, and relaxation training. Ye and Wang (2024) further validated the effectiveness of Baduanjin combined with routine nursing in patients with depression. After a 12-week intervention, HAMD scores significantly decreased from 1.28 ± 0.99 to 1.19 ± 0.11 (P < 0.001), demonstrating the clinical efficacy of this integrative approach.

Collectively, these studies indicate that combining Baduanjin with other therapeutic modalities not only enhances treatment outcomes but also highlights its broad applicability. Baduanjin can be effectively integrated with diverse treatment strategies, offering a versatile and complementary option for the prevention and management of depressive symptoms (Table 5).

Table 5:

Effectiveness of Baduanjin Combined with Other Interventions

Authors (Year)Study PopulationIntervention ProtocolOutcomes
Ma et al. (2023)Patients in the convalescent phase of COVID-19Received routine care plus Baduanjin exercise (15 minutes/session, twice daily) for 10 days.The intervention significantly reduced PHQ-9 scores from 15.54±2.68 to 10.03±1.25 in the observation group, showing greater improvement than the control group (P<0.01).
Wang et al. (2021)Patients with COVID-19Received routine care plus Baduanjin exercise (30 minutes/session, twice daily) combined with Five-Element Music therapy (30 minutes/session, twice daily) for 14 days.Post-intervention HAMD scores decreased significantly in the observation group and were lower than the control group (21±4 vs observation group's final score, P<0.05).
Wang et al. (2023)Asymptomatic individuals with COVID-19 infectionReceived routine care plus Baduanjin exercise (30 minutes/session, twice daily) combined with Five-Element Music therapy (30 minutes/session, four times daily) for 7 days.PHQ-9 scores reduced from 5.6±5.3 to 1.4±2.7 in the treatment group, with a between-group difference of 3.6 points versus controls (4.0±4.1, P<0.001).
Yan et al. (2024)Patients with moderate depressionReceived routine care plus Baduanjin exercise (40 minutes/session, once daily) combined with Relaxation Exercise (20 minutes/session, once daily) for 6 weeks.HAMD scores decreased from 24.75±4.62 to 6.55±3.44 (P<0.01) in the intervention group, with a total effective rate of 95.0%.
Ye & Wang (2024)Patients with major depressive disorderReceived routine care plus Baduanjin exercise for 12 weeks (45 minutes/session, 3 times/week with instructor for first 4 weeks; self-practice thereafter).The combined group showed significant reduction in HAMD scores from 1.28±0.99 to 1.19±0.11 (P=0.001).

In summary, findings from sixteen studies consistently demonstrate the significant efficacy of Baduanjin in the prevention and treatment of depression. Whether applied as a standalone intervention or in combination with Western pharmacotherapy, TCM, or psychological therapies, Baduanjin has been shown to markedly alleviate depressive symptoms, enhance emotional well-being, and improve overall health status. A substantial body of evidence further indicates that Baduanjin is not only effective among patients with comorbid conditions such as insomnia, cancer, or renal transplantation, but also beneficial for individuals experiencing physical frailty, contributing to improvements in muscle strength and functional capacity. Moreover, it plays a positive role in the prevention of depression and the promotion of mental health in broader populations. Therefore, the effectiveness of Baduanjin in the management of depressive disorders is unequivocal.

Safety Analysis of Baduanjin in the Prevention and Treatment of Depression

In managing depression, ensuring safety is as crucial as confirming therapeutic efficacy. Due to its low intensity, minimal risk, and notable adaptability, Baduanjin has emerged as an increasingly favorable and safe intervention option for depressive disorders.

Objective Safety

As a form of traditional Chinese mind–body exercise characterized by low intensity and minimal risk, Baduanjin involves slow, gentle movements with moderate amplitude and steady rhythm, resulting in relatively low physiological load. It is not only physically safe but also psychologically stabilizing, as its emphasis on breath regulation and mindful concentration fosters mental relaxation and reduces anxiety and tension. Patients with depression often present with comorbid conditions such as cardiovascular disease, diabetes, or chronic pain, which may limit their ability to engage in high-intensity physical activity. In contrast, Baduanjin consists of simple, easy-to-learn movements that can be flexibly adapted to individual physical capacities, thereby avoiding excessive strain on the cardiopulmonary or musculoskeletal systems.

Accordingly, the concept of “objective safety” in this context refers to the integrated safety profile of Baduanjin across exercise modality, physiological load, and psychological regulation. Its movement design inherently ensures low intensity and controllability, while the coordinated interaction of body and mind during practice promotes emotional balance—constituting a structurally embedded form of safety supported by both physical and psychological mechanisms. Moreover, Baduanjin practice is minimally constrained by time, space, or environmental conditions, further enhancing its feasibility and safety for widespread daily implementation (Ying, 2024).

Absence of Adverse Events as Reverse Validation of Safety

Across the 16 studies reviewed, the safety of Baduanjin as an intervention for depression has been extensively recognized and empirically validated. The majority of studies reported no serious adverse events, and multiple studies actively monitored physiological parameters such as complete blood counts and hepatic and renal functions, confirming that Baduanjin did not introduce significant physical stress while effectively alleviating depressive symptoms. For instance, studies conducted by Jing et al. (2018) and Suo & Yu (2016) have shown improvements in participants' quality of life and psychological well-being without notable adverse effects. Collectively, current evidence substantiates the favorable safety profile of Baduanjin, supporting its suitability for sustained use in depression management.

At the psychological level, Lv, et al. (2022) reported that no psychological or physiological discomfort occurred among participants in the experimental group during the six-week intervention. Patients experienced an “enhanced sense of relaxation and reduced anxiety” throughout the training process, suggesting that Baduanjin is psychologically safe, stable, and capable of regulating emotional states. Similarly, Wei et al. (2024) noted the absence of adverse psychological reactions or dropout events during Baduanjin practice, with students commonly reporting “improved mood and relief from anxiety” following each session.

Taken together, these findings indicate that Baduanjin demonstrates excellent safety across both physical and psychological dimensions, making it particularly suitable for long-term use as a therapeutic approach for individuals with depression.

A Flexible, Low-Risk Exercise Modality

Based on the studies reviewed, Baduanjin is suitable for the prevention and treatment of depression in various patient populations, particularly demonstrating good operability and safety in individuals with chronic diseases. Additionally, Baduanjin can be adapted to individuals with different health conditions, allowing for self-regulation of intensity to meet individual needs and reduce exercise-related risks.Thus, Baduanjin serves as a versatile, low-risk therapeutic modality that can be safely and effectively utilized by both healthy individuals and patients with specific health considerations, provided they receive appropriate guidance and practice self-regulation. Therefore, as a flexible and low-risk exercise intervention, Baduanjin is suitable for a wide range of populations. Whether applied to healthy individuals or those with special clinical needs, it can effectively reduce depressive symptoms when practiced under appropriate guidance and individualized adjustment.

Discussion

This study reviews existing research on the application of Baduanjin in the prevention and treatment of depression, with a particular focus on its efficacy and safety in alleviating depressive symptoms. It addresses a gap in earlier studies, which primarily examined exercise-based interventions using conventional modern exercise modalities, without specifically investigating Baduanjin or discussing its safety profile (Zhou & Ji, 2023).

This study systematically reviewed research on the application of Baduanjin in the prevention and treatment of depression, focusing on its efficacy and safety in alleviating depressive symptoms. It fills a gap in earlier studies, which primarily explored exercise-based interventions relying on conventional modern exercise modalities and did not specifically address Baduanjin or its safety profile.

The review findings indicate that Baduanjin, whether used as an independent intervention or as part of an integrated treatment approach, effectively alleviates negative emotions, reduces depressive symptoms, and improves quality of life (Ma et al., 2023). It demonstrates particularly strong applicability among middle-aged, elderly, and frail populations (Jing et al., 2018; Xiao et al., 2024). Therefore, individuals diagnosed with depression or exhibiting depressive tendencies may adopt Baduanjin as a therapeutic intervention and benefit from its practice.

However, several limitations should be acknowledged. First, the analysis primarily relied on qualitative descriptions, and the included studies lacked standardized protocols regarding the teaching and implementation of Baduanjin. Second, the literature search was restricted to English and Chinese databases, which may have resulted in incomplete coverage of relevant research. Third, this review provided limited discussion on direct comparisons between Baduanjin and other therapeutic modalities, as well as on its long-term efficacy; moreover, several included studies featured small sample sizes.

Future research on Baduanjin for depression should focus on expanding sample sizes, extending follow-up durations, standardizing intervention protocols, and conducting comparative studies with other alternative therapies. These efforts will enable a more comprehensive evaluation of its efficacy, long-term benefits, and relative advantages, thereby providing more robust scientific evidence for its clinical application and facilitating the global promotion of mental health through the integration of Baduanjin.

Practical/Social value

The study holds significant practical value for society: Baduanjin exercise, which requires no equipment and can be performed in any open space, is a low-cost, easily accessible form of exercise. It provides a safe, convenient, non-pharmacological intervention option for individuals with depression. The review findings indicate that whether practiced alone or combined with medication, psychotherapy, or other exercises, its significant efficacy and safety allow people of different ages and health conditions to engage in it. This method is particularly suitable for regions with limited medical resources or populations reluctant to rely on drugs.

This study aims to address two major social challenges: first, the growing population with depression has increased pressure on global medical resources, and this low-cost intervention can alleviate the strain on treatment resources; second, as some patients worry about drug side effects, Baduanjin can be regarded as a more acceptable alternative.

Understanding the current academic progress in Baduanjin intervention for depressive symptoms can provide a more scientific basis and options for the treatment of more people with such symptoms. For global mental health, this study enriches the diversity of global mental health interventions and offers a Chinese practical example for non-pharmacological treatment of depression, contributing to the construction of a more inclusive and diverse global mental health system.

Conclusions (and Future Work)

Current evidence clearly indicates that Baduanjin can significantly regulate mood, reduce depressive symptoms, and enhance quality of life in the general population. Furthermore, it has been shown to improve mental health across diverse demographic groups, with particularly strong applicability among older adults and individuals with physical frailty.

Most experimental studies to date suffer from small sample sizes, brief follow-up periods, insufficient standardization of intervention protocols, and incomplete reporting of adverse events. These shortcomings appear to be driven, in part, by constrained research resources and funding, which restrict many investigators to small-scale trials owing to the difficulty of recruiting specific cohorts of patients with depression. Time limitations likewise shorten follow-up windows, hampering assessment of sustained effects. Protocol heterogeneity arises from regional and population-specific variations in Baduanjin practice, prompting researchers to tailor routines to participant characteristics. Finally, because Baduanjin is widely regarded as a low-risk exercise, some studies have devoted insufficient attention to monitoring and detailed reporting of adverse reactions.

Future investigations of Baduanjin for depression should aim to increase sample sizes, extend follow-up durations, standardize intervention protocols, and include head-to-head comparisons with other complementary therapies. Such efforts will allow a more comprehensive appraisal of efficacy, long-term outcomes, and relative advantages, thereby furnishing stronger scientific support for clinical implementation.

Language: English
Page range: 169 - 182
Submitted on: Aug 20, 2025
Accepted on: Oct 24, 2025
Published on: Nov 2, 2025
Published by: International Platform on Mental Health
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Shuchang Liu, Changxin Luo, Guodong Zhang, published by International Platform on Mental Health
This work is licensed under the Creative Commons Attribution 4.0 License.